4D Molecular Therapeutics Inc

Research 4D Molecular Therapeutics Inc (FDMT) on Bullrun: market cap USD 673.32M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerFDMT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 673.32M
• Financial periodFY2025
• RevenueUSD 85.21M
• Revenue growth230194.6%
• Net income-USD 140.11M
• Free cash flow-USD 109.62M

Valuation Snapshot

latest market cap is USD 673.32M.

About 4D Molecular Therapeutics Inc

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Frequently asked questions

What is 4D Molecular Therapeutics Inc's market cap?

4D Molecular Therapeutics Inc's market capitalization is USD 673.32M.

What does 4D Molecular Therapeutics Inc do?

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.